-
Viesearch·
-
@rcshealthcareeditor·
CorDx Tyfast SARS-CoV-2/Flu A+B Rapid Antigen Test
The CorDx Tyfast SARS-CoV-2/Flu A+B Rapid Antigen Point-of-Care Test is a lateral flow immunoassay for in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigens. It detects SARS-CoV-2, influenza A, and influenza B directly from anterior nasal swab specimens from patients suspected of COVID-19 by their healthcare provider, within the first five days of symptom onset.